Aimei Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aimei Liu has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Chenchen Song
School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China
3 shared publicationsPengju Wang
Hubei Key Laboratory of Diabetes and Angiopathy, Medicine Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China
3 shared publicationsYu Hua
Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China
3 shared publicationsQing Yao
Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Hubei University of Science and Technology, Xianning, People’s Republic of China
2 shared publicationsQirong Lu
Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China
2 shared publicationsWei Wang
School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning Hubei 437100, China
2 shared publications
Latest Publications
- 19 February 2025
- Published by Elsevier in Toxicology
- Vol. 513, 154084
NNMT is involved in deoxynivalenol-induced hepatocyte toxicity via promoting ferroptosis
- 19 February 2025
- Published by Elsevier in Toxicology
- Vol. 513, 154084
NNMT is involved in deoxynivalenol-induced hepatocyte toxicity via promoting ferroptosis
- 9 November 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (3) , 875-884
Mesenchymal stem cell-derived exosomes in renal ischemia–reperfusion injury: a new therapeutic strategy
- 9 November 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (3) , 875-884
Mesenchymal stem cell-derived exosomes in renal ischemia–reperfusion injury: a new therapeutic strategy
- 13 August 2024
- Published by Elsevier in Toxicology
- Vol. 508, 153923
CYP2E1 mediated deoxynivalenol-induced hepatocyte toxicity by regulating ferroptosis
- 13 August 2024
- Published by Elsevier in Toxicology
- Vol. 508, 153923
CYP2E1 mediated deoxynivalenol-induced hepatocyte toxicity by regulating ferroptosis
- Open Access
- 1 March 2024
- Published by KEAI Publishing in Animal Nutrition
- Vol. 16, 251-266
Effective protective agents against the organ toxicity of T-2 toxin and corresponding detoxification mechanisms: A narrative review
T-2 toxin is one of the most widespread and toxic fungal toxins in food and feed. It can cause gastrointestinal toxicity, hepatotoxicity, immunotoxicity, reproductive toxicity, neurotoxicity, and nephrotoxicity in humans and animals. T-2 toxin is physicochemically stable and does not readily degrade during food and feed processing. Therefore, suppressing T-2 toxin-induced organ toxicity through antidotes is an urgent issue. Protective agents against the organ toxicity of T-2 toxin have been recorded widely in the literature, but these protective agents and their molecular mechanisms of detoxification have not been comprehensively summarized. In this review, we provide an overview of the various protective agents to T-2 toxin and the molecular mechanisms underlying the detoxification effects. Targeting appropriate targets to antagonize T-2 toxin toxicity is also an important option. This review will provide essential guidance and strategies for the better application and development of T-2 toxin antidotes specific for organ toxicity in the future.
- 1 March 2024
- Published by KEAI Publishing in Animal Nutrition
- Vol. 16, 251-266
Open AccessEffective protective agents against the organ toxicity of T-2 toxin and corresponding detoxification mechanisms: A narrative review
T-2 toxin is one of the most widespread and toxic fungal toxins in food and feed. It can cause gastrointestinal toxicity, hepatotoxicity, immunotoxicity, reproductive toxicity, neurotoxicity, and nephrotoxicity in humans and animals. T-2 toxin is physicochemically stable and does not readily degrade during food and feed processing. Therefore, suppressing T-2 toxin-induced organ toxicity through antidotes is an urgent issue. Protective agents against the organ toxicity of T-2 toxin have been recorded widely in the literature, but these protective agents and their molecular mechanisms of detoxification have not been comprehensively summarized. In this review, we provide an overview of the various protective agents to T-2 toxin and the molecular mechanisms underlying the detoxification effects. Targeting appropriate targets to antagonize T-2 toxin toxicity is also an important option. This review will provide essential guidance and strategies for the better application and development of T-2 toxin antidotes specific for organ toxicity in the future.
- 26 October 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 182, 114121
Effective protective agents against organ toxicity of deoxynivalenol and their detoxification mechanisms: A review
- 26 October 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 182, 114121
Effective protective agents against organ toxicity of deoxynivalenol and their detoxification mechanisms: A review
- 5 July 2023
- Published by Elsevier in Toxicology
- Vol. 494, 153589
Resveratrol protects against deoxynivalenol-induced ferroptosis in HepG2 cells
- 5 July 2023
- Published by Elsevier in Toxicology
- Vol. 494, 153589
Resveratrol protects against deoxynivalenol-induced ferroptosis in HepG2 cells